CM-93

N/A

Report date: 2023/01/07 17:46:00
NME

Base Information

Drug NameCM-93
Drug Alias NameCM-93
ClassificationSmall molecules
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesShanghai Crimson Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCrimson Biopharm IncShanghai Crimson Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A